共 50 条
- [1] PRELIMINARY RESULTS FROM AN OPEN-LABEL, MULTICENTER, PHASE II STUDY OF BENDAMUSTINE IN RELAPSED OR REFRACTORY T-CELL LYMPHOMA FROM THE FRENCH GOELAMS GROUP: THE BENTLY TRIALANNALS OF ONCOLOGY, 2011, 22 : 125 - 125Damaj, G.Gressin, R.Bouabdallah, K.Martin, A.Houot, R.Park, S.Jaccard, A.Le Gouill, S.Cony-Makhoul, P.Banos, A.Coso, D.Voillat, L.Gyan, E.Cartron, G.Lamy, T.
- [2] Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY TrialJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 104 - 110Damaj, GandhiGressin, RemyBouabdallah, KrimoCartron, GuillaumeChoufi, BachraGyan, EmmanuelBanos, AnneJaccard, ArnaudPark, SophieTournilhac, OlivierSchiano-de Collela, Jean-MarcVoillat, LaurentJoly, BertrandLe Gouill, StevenSaad, AlainCony-Makhoul, PascaleVilque, Jean-PierreSanhes, LaurenceSchmidt-Tanguy, AlineBubenheim, MichaelHouot, RochDiouf, MomarMarolleau, Jean-PierreBene, Marie-ChristineMartin, AntoineLamy, Thierry
- [3] A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)LEUKEMIA & LYMPHOMA, 2019, 60 (13) : 3251 - 3257Park, Byeong-BaeKim, Won SeogSuh, CheolwonHong, Jung YongYang, Deok-HwanLee, Won SikDo, Young RokKoh, Young IlWon, Jong-HoKim, Min KyoungJo, Jae-CheolHyun, Shin YoungKim, Jeong-AOh, Young HaLee, Seung-Sook
- [4] Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphomaLEUKEMIA & LYMPHOMA, 2011, 52 (08) : 1474 - 1480Querfeld, ChristianeKuzel, Timothy M.Kim, Youn H.Porcu, PierluigiDuvic, MadeleineMusiek, AmyRook, Alain H.Mark, Lawrence A.Pinter-Brown, LaurenHamid, OdayLin, BorisBian, YingBoye, MarkDay, Jeannette M.Rosen, Steven T.
- [5] Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin LymphomaJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 456 - 460Moskowitz, Alison J.Hamlin, Paul A., Jr.Perales, Miguel-AngelGerecitano, JohnHorwitz, Steven M.Matasar, Matthew J.Noy, ArielaPalomba, Maria LiaPortlock, Carol S.Straus, David J.Graustein, TriciaZelenetz, Andrew D.Moskowitz, Craig H.
- [6] Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trialCHINESE MEDICAL JOURNAL, 2024, 137 (13) : 1576 - 1582Liang, JinhuaWang, LiWang, XiaodongCui, GuohuiZhou, JianfengXing, TongyaoDu, KaixinXu, JingyanWang, LuqunLiang, RongChen, BiyunCheng, JianShen, HaoruiLi, JianyongXu, Wei
- [7] A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) TrialBLOOD, 2016, 128 (22)Park, Byeong-BaeKim, Won SeogSuh, CheolwonYoon, Dok HyunWon, Jong-HoYang, Deok-HwanDo, Young-RokLee, Won SikKim, Jeong-AKim, Min KyoungJo, Jae-CheolKoh, Youngil
- [8] Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial中华医学杂志英文版, 2024, 137 (13)Liang JinhuaWang LiWang XiaodongCui GuohuiZhou JianfengXing TongyaoDu KaixinXu JingyanWang LuqunLiang RongChen BiyunCheng JianShen HaoruiLi JianyongXu Wei
- [9] Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell LymphomaBLOOD, 2016, 128 (22)Ogura, MichinoriMaruyama, DaiTobinai, KenseiUchida, ToshikiHatake, KiyohikoTaniwaki, MasafumiAndo, KiyoshiTsukasaki, KunihiroIshida, TakashiKobayashi, NaokiIshizawa, KenichiTatsumi, YoichiKato, KojiKiguchi, ToruIkezoe, TakayukiLaille, EricRo, TokihiroTamakoshi, HiromiSakurai, SanaeOhtsu, Tomoko
- [10] A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphomaExperimental Hematology & Oncology, 11Nobuhiko NakamuraSenji KasaharaJunichi KitagawaHiroshi NakamuraMichio SawadaKenji FukunoYuhei ShibataYuto KanedaTakeshi HaraNobuhiro KanemuraHisashi TsurumiMasahito Shimizu